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Introduction
For myself, the most difficult part of the thesis process was choosing its topic.
Not only did I want to find a topic that would hold my interest, but it also had to be one to
which I could personally relate. Multiple myeloma came to my attention a number of
years ago, when my aunt was diagnosed as having the disease. It seemed only natural
that this disease, which at the time myself and my family knew little about, would
become the focus of my graduate thesis.
Upon arriving at this decision, a thesis proposal was drawn, listing my primary
goals. In its original form, the proposal described "developing a series of posters, which
would illustrate the symptoms of multiple myeloma, as well as its histology and physical
manifestations." As my work progressed, so did this original intent. The thesis evolved
into a series of illustrations, "posters" and slide graphics, to be displayed, in its final
form, as a medical exhibit.
The most crucial element of this thesis was the researching of multiple myeloma.
While the artwork is the final result, and that which will be judged, it is the information
which I attained that allowed for its creation. Researching began at the Edward G. Miner
Library of the Rochester Medical Center/Strong Memorial Hospital. The search for
information followed by consulting immunology texts. These books gave a general
overview of the disease upon which further research could expand. From there, books
specifically related to the disease were sought and found. However, the most recent of
these had been published in 1 985. To ensure that the information presented within
these books was not outdated, the MEDLINE database was consulted. This database
provided a list of the most recently published journal articles written on multiple
myeloma. With this in hand, the thesis was begun.
Multiple Myeloma
Multiple myeloma is primarily a disease of the plasma cells that manifests as
localized tumors, particularly in the long bones. Bone marrow and organ infestation is
characteristic of the disease as well; it is a neoplasia. The underlying mechanism of this
condition is an abnormal production of protein that is circulated though the body,
deposited in body tissues, and may be excreted in the urine. To understand the
aforementioned
"mechanism,"
and ensuing symptomatology, it is first necessary to
explore immunolgobulins and their functions in the healthy individual. The human
immune system may stimulate a response to a substance that it finds toxic; these
substances are referred to as antigens. Antigens may be of either the exogenous or
endogenous variety. The former are those that are presented to the host via the
exterior environment, while the latter are found within the individual.
Plasma cells produce antibodies (immunoglobulins), which bind to and eliminate
antigens. The basic structure of the immunoglobulin molecule is formed by four
polypeptide (amino acid) chains bound together by disulfide bonds. Two heavy chain
and two light chain components represent the polypeptide chains, each with a constant
and a variable region; the variable region is that which binds to the antigen. Different
types of monoclonal proteins (immunoglobulins) are designated by capital letters that
correspond to their heavy chains; G, A, D, E, or M sequence. There are only two
possible light chain sequences, Kappa or Lambda.
Each immunoglobulin class performs specific functions within the immune
system. Three fourths of the serum proteins produced in the body are of the
immunoglobulin G (IgG) type. IgG is thought to defend against those infecting agents
that disseminate via the circulatory system: bacteria, viruses, parasites, and some fungi.
Complement activation, and antibody activity in tissues, is carried out by IgG as well. Of
the immunoglobulins, only IgG is capable of crossing the placenta.
IgA is the second most abundant immunoglobulin in the body. It is a secretory
immunoglobulin, produced in the lymphoid tissues lining the respiratory, gastrointestinal,
and genitourinary tracts. The immunity benefits of IgA are transferred to the newborn
through the lactating mothers' colostrum.
IgM is restricted almost entirely to the intravascular space, and is a highly
efficient fixer of complement. Its greatest role is played in the first few days of a primary
immune response as a predecessor of IgG. IgE initiates allergic reactions; no specific
role has been found for IgD.
The chief antagonist in multiple myeloma is the myeloma cell; it is an atypical
neoplastic plasma cell. In hematoxylin and eosin stained preparations the tumor is
characterized by sheets or infiltrations of these cells. Typically they exhibit a basophilic
cytoplasm, eccentric nucleus, and one or more nuclei.
In the development of plasma cells from their precursor, DNA rearrangement
allows for numerous plasma cell clones, each making specific immunoglobulins. In
multiple myeloma one of these clones is selected for uncontrolled and abnormal
production. This proliferation yields synthesis of large amounts of a single monoclonal
immunoglobulin; it is referred to as (M) protein. Consequently, the (M) protein may be
any one of the immunoglobulin types (IgG, IgA, etc.). As well, it may be a Bence Jones
protein (light chain myeloma), in which there are free Kappa or Lambda chains. The
Bence Jones proteins are, in many cases, excreted into the urine. Finally, the
monoclonal protein may be of both; an immunoglobulin and a Bence Jones protein. It
should be noted that a fourth case does exist in which no (M) protein can be detected in
either the patients' serum or urine. This condition is designated
"nonsecretory"
myeloma. [The frequency of occurrence of each of the above types is represented in
Fig. 9]
Plasma cell dycrasia (PCD) is a term for those diseases in which there is an
overproduction of a monoclonal protein. While this is occurring there is often a decrease
in the production of the normal immunoglobulins. In example, in an IgG multiple
myeloma, IgG and IgM levels are reduced. This often leads to repeated infections. The
cause of PDC, and thus multiple myeloma, is not fully understood, though the major risk
indicator is old age. Some theories include chronic antigen stimulation, viral
transformation of B- lymphocytes (the precursor of plasma cells), loss of regulatory cell
function, as well as others.
Multiple myeloma's involvement is widespread throughout the organs and
systems of the body. Symptomatically, it is most often bone pain that leads patients to
seek a physician's aid. Pain typically manifests in the chest or back and less often the
limbs; "it is present at the time of diagnosis in almost 70% of cases." (Kyle and Bayred
1976, 76) The pain results from a combination of osteolytic lesions, diffuse
osteoporosis, and compression fractures.
Within the skeletal system, we primarily see osteolytic lesions in the axial
skeleton, as well as in the proximal portions of the long bones (ie. humeri). Through
roentgenograms (x-rays), four general classifications for multiple myeloma's skeletal
infestation have been made: "(1) generalized bone resorption without plasmacytomas
[tumors]; (2) bone resorption combined with round or oval osteolytic lesions caused by
plasmacytomas; (3) one or many round or ovoid osteolytic lesions without clearcut
generalized resorption of bone; (4) an apparently normal
skeleton." (Snapper and Kahn
1971, 157)
When viewing specimens microscopically there is evidence of an increase in the
number of osteoblasts neighboring the myeloma cells. Osteoclasts function in the early
stages of bone remodeling, acting as a bone-resorbing cell. They are large
multinucelated cells whose resorption mechanism is not fully understood; it may be a
process by which secreted organic acids dissolve the calcium from the bone matrix,
followed by the digestion of the collagen fibers. As well, an answer for the increased
number of osteoclasts present in the myeloma patient has not yet been found. It is
suggested that there is an osteoclast-stimulating factor produced in the course of the
disease, "similar to that derived from activation of normal leukocytes." (Jacobs 1990,
337)
Skeletal involvement, in many cases, leads to neurologic involvement and
damage. Vertebral fractures, and collapse, put undue pressure on the spinal cord;
most often the thoracic area is involved. This disturbance can result in a degeneration
of the peripheral nerves, hindering both motor and sensory functions. Frequently,
paraplegia is the final consequence. In addition to the spinal cord, the brain itself may
be affected. Intracranial plasmacytomas have been documented, though they are
usually extensions of skull based tumorsl. Finally, the symptoms of lethargy, stupor,
and coma may become apparent. These central nervous system disorders may be in
part due to an increased blood viscosity in the myeloma patient; the overproduction of
immunoglobulins contributes to the increase.
The excess of free light chains in the urine is referred to as Bence Jones
proteinuria; this often leads to renal failure in the multiple myeloma sufferer. Under
normal circumstances, the kidney is able to process these free chains; an impaired
kidney cannot. The result is an increase in the urinary and serum concentrations of
Bence Jones proteins; this occurrence has detrimental results. Proteinaceous,
laminated casts form within the distal, and sometimes proximal, convoluted tubules,
causing glomerular shutdown, and renal failure. The casts are composed of albumin,
IgG, and light chains of both the kappa and lambda types. Additionally, the myeloma
kidney may suffer damage as a result of other complications: through plasma cell
infiltration of the renal parenchyma; through amyloidosis (protein deposition); through
hypercalcemia; through hyperuricemia. (Bernier 1985, 450) Just as tumors of the
skull often enter into the brain, plasmacytomas that originate in the rib cage often invade
the lungs. The respiratory system is further complicated by myeloma cells infiltrating the
pleural fluid. Pleural effusion (leakage) may occur in the patient resulting in labored
breathing. Finally, there is evidence of hepatic, cardiac, integumentary, optic, splenic,
lymphiod, and glandular involvement as well.
With all the above, the prognosis for the individual with multiple myeloma is not
good; the survival rate is about one to three years from the time of diagnosis.
Through this paper, it is my goal to present the reader with a general
understanding of multiple myeloma. In addition, I have attempted to explain my artwork
in terms of significance, meaning, and technique. Hopefully, all of this has been
achieved.
Artwork
Multiple Myeloma: Human Interest (Fig. 1)
With this piece it was my goal to create a visual introduction to multiple myeloma.
It is an attempt to portray the disease from a humanistic view, while maintaining
scientific accuracy and interest. The images depicted consist of a plasmacytoma
(tumor) within the sternum, cell differentiation and immunoglobulin production, as well
as a
"generic"
myeloma sufferer. From the onset of its production, I had decided that
the visual focus of the piece would be the patient, and thus composition and layout
began with the portrait. The next image incorporated was the tumor. The sternum was
chosen to house the tumor because it is a primary site of incidence. I, as well, found
that the rib cage acted as a natural border for the piece. Finally, the cells and
immunoglobulins were added, as they are the basis for the disease's manifestations.
When looked upon as a whole, the images represent a hierarchy of the disease: it
takes the viewer from the microscopic to the gross, from the cause to the result.
The execution of this illustration began with research and the search for
reference. Throughout my research, I found photographs of both myeloma cells and
associated tumors. These were used to create a
"composite" tumor that was then
placed within a sternum, drawn from observation. Although I was able to accurately
render cells from slide and photograph observation accurately, their associated
immunoglobulins are too small to view. Instead they were based on written descriptions
of their structure, and standard text book models. The portrait was derived from
photographs of my grandfather (who is not a sufferer of the disease).
After arriving at a final sketch, the image was transferred to a piece of Cresent
"English Rose" mat board. The illustrating began by airbrushing a gradated reddish
earthtone (alizarin crimson and burnt sienna watercolor), from the top downwards to the
halfway mark, and from the bottom upwards, about one quarter of the way. This served
as the base color for this piece, as well as for the others in the series. Next, the portrait
was rendered monochromatically in terracotta pencil, Berol's Verithin brand. The
background color served as a middle value, and highlights were added last, using a
white colored pencil. This manner of representation was chosen so that the emotion in
the face would prevail over the color. There is an attempt to show a glimpse of hope,
through the wide open eyes and apprehensive smile, though faced with such a terrible
disease.
The sternum, rib cage, and associated tumor were also rendered in colored
pencil (Prismacolor and Verithin). Bone color was achieved through a series of layers ol
white, creams, and browns, going lightest to darkest; highlight were then reinforced.
Violets were also used in the shadow areas of the bone. Creating a sense of depth in
the trabeculae and marrow cavity presented a challenge. A goal of this illustration was
to keep an organic sense of the bone; not getting too stylized. The use of color was the
answer to this problem. By varying the color in the trabeculae and cavity, the perception
of depth and form was altered. Cooler colors, in the
"deeper"
areas, caused a greater
perceived recession, while warmer colors moved forwards; an overall planar change
was achieved. The tumor presented its own problems. It was not my wish to place a
red splotch amidst the bone and call it a tumor. The illustration was to be rendered in a
realist manner, and thus the tumor had to carry the same weight and form as the bone.
A number of reds and oranges were used to convey changes in the shape and density
of the tumor. Violets and blues gave way to those areas that lay in shadow, and strong
white highlights added the shine of a
"live"
specimen. As a final accent, terracotta
pencil was added around the rib/sternum junctions to
"lift" the object from the
background.
Another goal of this illustration was to create cells that appeared as solid,
translucent, three dimensional objects. This meant creating the illusion that cell's
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contents were individual objects floating within. While the two cells are unique to
themselves, the process of rendering was the same, and thus they will be spoken of as
one. The cells are rendered as those that have been prepared with Wright's stain. The
first step was to fully render the nuclei and nucleoli. Each was given a mid-tone, core
shadow, highlight, and an indication of reflected light. Next, the cell body was rendered.
This included the cytoplasm, mitochondria, golgi, and endoplasmic reticulum. Finally,
the outside membrane was colored using a series of blues and violets. Again, shadows
and highlight were incorporated to create a sense of solidity; successive layers of
Prismacolor white and flesh were used for the reflected light. A model of the
immunoglobulin was made from Sculpey modeling compound to be used as a
reference. This allowed for a greater understanding of both perspective and light
(reflections and shadows), in relation to an object of this shape. Prismacolor and
Verithin pencils were used in the coloring of the molecules, as well as the arrows. A
metal straight edge and french curves were also employed in the arrows' creation. An
outline was created using a white Verithin pencil; the color was gradated evenly
inwards. A terracotta pencil outline on the shadow side of the arrows finished the piece.
Overview of Symptoms (Fig. 2)
The purpose of this illustration is to visually provide, on a gross level, an overall
view of the symptomatology of multiple myeloma. The piece portrays the primary areas
for tumor infestation, as well as neurologic, respiratory, hepatic, and renal involvement.
However, the illustration is not intended to show the resulting damage, but instead to
give an indication ofwhere it occurs; only the liver shows resultant enlargement.
The chosen ground for this illustration is 300 Ib. Arches brand watercolor paper,
which was stretched over a wooden frame. While this paper is a bit unconventional for
this type of illustrating, it was chosen for a number of reasons. I have found that
gradated tones are achieved more easily with this paper, and that it is less easily
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"overworked" than illustration board. Additionally, the paper's texture added the organic
quality that I sought to achieve in this illustration. The entire work was done in
watercolor; as a foreword, it should be mentioned that honey was mixed into the water
that was used in the painting process. Honey acts to slow the drying process, and
allows more working time with the paint laid onto the paper.
The piece began with research into the symptomatology of multiple myeloma,
and with sketching from both observation and photographs. Upon completion of a final
sketch, the drawing was transferred to the stretched paper. The painting process began
with the skeleton, rendered without its associated periosteum. The first wash was a
dilute yellow ochre, which was laid down slightly lighter in the highlight areas and darker
in the shadow areas. The shadows were then reinforced with a dilute violet wash.
Subsequent washes of yellow ochre were used to elevate the modeling of the bone. A
mixture of yellow ochre and burnt sienna created a warmer tone, which helped to
delineate much of the form of the bones. Cooler mixtures of the base color (y. ochre, b.
sienna, and cobalt blue), as well as burnt umber, were used in the modeling of the
shadow areas. Details, such as the sutures within the orbits and the teeth, were
achieved with aWindsor & Newton, series 3A #0, sable brush. Finally, highlights were
both scrapped and erased in.
The organs and tumors were rendered after the skeleton was complete. The
brain was painted so as to appear ghosted into the skull. This was achieved by painting
a bolder outline, and then fading the color inwards. This technique is also apparent
where one object covers another; where the sternum covers the lungs, and where the
liver overlaps the kidneys. The lungs were created through a series of pink and violet
washes. A darker value of violet was created with the addition of alizarin crimson and
cobalt blue, and was used on the shadow side of the lungs. This color was also added
at the sternum-rib junctions and below the ribs, in order to
"lift" the cage off of the lungs.
Using a detail brush, the lobular pattern was added to the lungs, in an attempt to
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emulate their in situ appearance. The liver color was achieved with a mixture of alizarin
crimson and burnt sienna. The addition of cobalt blue to the base color gave way to the
shadow color. The kidneys followed the same basic color scheme as the liver, but went
towards the violet end of the mixture. The plasmacytoma color was a mixture of
cadmium red medium and alizarin crimson. Again, a ghosted image was created for the
tumors. An outline was created, and a lighter value of the color was faded inwards.
The placement of the plasmacytomas was dictated by their primary areas of incidence.
However, size, shape, and location (side of the body) were selected in such a way as to
keep the image balanced.
Conceptual Representation:
Mveloma Cells and Immunoglobulins Within the Marrow Cavity (Fig. 3)
The purpose of this work was to create a conceptual representation of the
myeloma cells, and their associated (M) proteins, within the environment in which they
proliferate, the marrow cavity. From its onset, this was to be a full color, conceptual
illustration. However, I did not know in what manner to approach it. Sketches began
with a cross section of a long bone (ie. humerus), looking into the marrow cavity. This
progressed to an enlarged view in which the observer would actually be placed within
the marrow cavity, though above the plane of the section; an aerial perspective. A
stylized system of caverns became representative of the trabeculae; the same
conventions (from the first illustration) were upheld for representing the cells and
immunoglobulins. A final sketch of the "bony" landscape was completed, and then
transferred to cold press illustration board. The molecules and cells were then
transferred as well. While the size and shape of the trabeculae are
"realistic," those of
the molecules and cells are greatly exaggerated. Scale became unimportant in this
illustration, as it is conceptual; the object of the illustration was not to render a histologic
preparation, but was instead to visually interpret the "goings
on"
within the marrow
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cavity. As well, there are many elements indigenous to the marrow cavity which have
been excluded from the illustration. This was done so as not to distract from the
information that the piece is intended to deliver; the myeloma cells and immunoglobulins
within the cavity.
Having fully transferred each element onto the board, the illustrating process was
begun. The first step involved an underpainting of the cavity landscape. A dilute wash
of yellow ochre (watercolor) was used to create an overall sense of form and structure;
a second, darker wash gave a hint towards shadows. A dual purpose was served with
the underpainting. Along with the general form, a more organic surface texture is
perceived under the airbrush work. The endoplasmic reticulum of the myeloma cells
was also painted at this time, using a bluish violet.
Following the underpainting, the entire board was covered with frisket and each
shape was cut out (a #1 1 X-acto blade was used). Circle templates and a metal straight
edge were used in the cutting out of the molecules in order to maintain the integrity of
their shapes. Each piece of the background was removed, in turn, and a base color of
yellow ochre and burnt sienna was airbrushed on; form, shadow, and highlights were
rendered, keeping "in
synch"
with the underpainting. Core shadows were reinforced
with a deeper value of the base color, plus cobalt blue, and airbrushed in a direction
facing away from the highlight area. The more recessed trabecular
"caverns"
were
given an overall spray of the aforementioned color, in order to diminish contrast and
increase the illusion of depth. Cast shadows, emanating from bone, were created with
neutral grays; those in the distance were done with a burnt sienna/cobalt blue mixture,
while those in the foreground had alizarin crimson in the mixture as well. As a final step,
the frisket was removed from the trabeculae (except those in "direct light"; bottom right
corner), and a mixture of burnt sienna and alizarin crimson was lightly sprayed from the
bottom right, upwards to the top left. This brought a greater sense of unity and
increased depth of field.
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With the frisket replaced and repositioned, it came time to render the
immunoglobulin molecules. Cobalt blue was chosen for the light chain base color, and
a violet/alizarin mixture for the heavy chains. In a manner similar to that of the
trabeculae, the molecules were airbrushed. I began by creating a general form;
midtone, highlight, and core shadow were painted with varying layers of base color.
The core shadow was then reinforced with a deeper hue: a cobalt blue and burnt sienna
mixture for the light chains; an alizarin crimson, violet, and cobalt blue mixture for the
heavy chains. Reflected light was achieved with the trabeculae base color, plus white.
Badger brand Opaque-Air white was used to reinforce the highlights, as was a white
charcoal pencil.
The cell rendering process began with the trabeculae base color. This was
airbrushed radially outwards from the center of each cell. The intention here was to
create a basis for the cell's translucency. Alizarin crimson was the base color for the
nuclei. The color was put on so that the edge facing the light was darkest in value, and
an oval shaped area, close to the opposite edge, was given very little color. An Alizarin
crimson/cobalt blue mixture provided color for the core shadow and nucleoli; it was also
used to darken the "light" edge. This technique was repeated, with a blue-violet color,
for the cell body. Low air flow, combined with high paint flow in the airbrush, produced
the cytoplasmic texture within the cell. White charcoal was used for the highlights on
the cells.
As an aside, it must be added that cast shadows, emanating from the cells and
immunoglobulins, were foregone. There was a concern that their presence would cause
confusion between the actual and representative size of the cells and immunoglobulins.
Slide Graphics (Figs. 4 through 10)
While each illustration in this series could lend itself to a variety of roles, their
primary intention was to be used collectively in an exhibit. However, the slide graphics
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serve a specific, dual role. They were created not only for display in the exhibit, but also
to be used as an educational aid in any lecture which may accompany the exhibit.
Each of these images (Figs. 4 through 10) was created on an Apple Macintosh,
Ilex computer, utilizing 24-bit color. The final images were printed on a Kodak XL7700
printer, and recorded onto slide film using a Montage film recorder and Image Q
software. All of the images were created in the same basic manner, which will now be
discussed. The specifics of each image will be discused later in this paper.
Sketches were made of each slide graphic, and then scanned into the Adobe
Photoshop program using the Silverscan driver package. This provided a template
which was then opened in Adobe Illustrator. Using the pen tool, each element was
traced from the templates; a base color was added to each using the style/paint option.
The background was also created while in the Illustrator program. Thin boxes, which
spanned the width of the image area, were created with the rectangle tool and then
placed at both the top and bottom of the illustration. Colors for a blend were chosen,
and the rectangles painted (without an outline) using the style option. The blend tool
was employed, and a gradated blending of the two colors created the background. This
was
"grouped"
and moved to the back, so that the foreground objects would be
unobstructed and visible. The images were then saved under the heading "Preview
Color Macintosh," for import into Photoshop. Once opened in Photoshop, a dialog box
appeared, and options were set: resolution at 72 dpi (dots per inch); RGB (red, green,
blue) mode; anti-aliasing on. The last was initiated to reduce
"stair-stepping." "Stair
stepping" describes the jagged appearance of curved lines in computer generated
graphics. The anti-aliasing option blends the line color with its adjacent color, creating a
smoother perceived line. The Photoshop toolbox provided the tools (ie. airbrush,
paintbrush) used in the rendering and retouching of each image. Finally, the type tool
was used to add text to the illustrations. Size, font, style, and anti-aliasing were all
14
chosen via the dialog box; the dialog box was initiated by double clicking the mouse on
the type tool. The font chosen was Garamond Bold.
At this point it was possible to record the images onto slide film. However, a
greater image resolution was required for the Kodak prints; 200 dpi was optimal.
Copies of each image had been saved, without text. The resolution of these images
was altered, using the image/size option. Within the dialog box, "file size" was
deselected, and the resolution was re-entered at 200 dpi. This changed the resolution,
while keeping the image at its original dimensions (6x9 in.). The computer's re-
interpretation of the data caused some undesirable changes to the illustration; some
lines became jagged. This was remedied by using the blur tool to smooth over the
disrupted lines and areas. Labels were created and positioned, and the images, now
over 6 megabytes each, were saved onto a 44 mb Syquest cartridge. The cartridge was
then taken to Precision Imaging, Rochester, NY, who outputted the images onto the
Kodak printer.
The aforementioned is a description of the general method used in the creation of
the slide graphic series. There are, however, more specific techniques that were used in
the illustration process. While the creation of each element is not discussed, each came
about through similar means as those described below.
Mveloma and Plasma Cells (Figs. 4, 5, & 9)
The basic shape and color for these cells was created in Adobe Illustrator; the
rendering for each was done in Photoshop. The first step was to create a cytoplasmic
structure within the cells. A new file was opened in Photoshop and the Gray scale
mode was chosen. Using the rectangular marquee tool, a gray square of medium value
was created and left sefected. The noise filter was activated so as to randomly add
pixels of different value, creating a speckled pattern. The rectangle was then scaled to
a size larger than that of the cells. Blurring the image gave a softer feel to the pattern.
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The selected image was copied. Returning to the original illustration, the cell to be
rendered was selected and the paste-into function was activated. This placed the
pattern within the cell. With the cell still selected, the paste controls (under the edit
menu) allowed for the manipulation of the recently pasted image; its opacity was altered
to allow the original cell structure and color to show through. Image/adjust allowed for
the adjusting of color balance, hue, and saturation. The nucleus was then selected with
the magic wand tool. By selecting the nucleus, a mask was created over the rest of the
illustration; this meant that only the selected area could be altered. The form and color
of the nucleus were achieved utilizing the paintbrush, airbrush, smudge, and blur tools.
Once completed, the nucleus was deselected and the entire cell selected. Background
color was picked up with the eyedropper tool, and airbrushed into the cytoplasm area.
This was done to re-emphasize the translucence of the cell. Endoplasmic reticulum was
created with the paintbrush tool and smoothed with the blur tool, as were the other
elements within the cells. Modeling and shadow were achieved with a series of violets
and blues applied with the airbrush tool. The highlights were shaped with the pen tool
and colored with the airbrush.
Photo Insets (Figs. 6 & 8)
Both the skull roentgenogram and the cross section of cerebral hemispheres
began as photographs in The Monoclonal Gammopathies: Multiple Mveloma and
Related Plasma-Cell Disorders (Kyle and Bayrd, 1976). Each image was scanned into
Photoshop using the Silverscan driver package, under the file menu acquire option.
Next, the images were selected with the rectangle marquee for rendering. Image/adjust
allowed for an overall balance of brightness and contrast. The affected areas, in each
image, were selected with the same tool. The smoother appearance in these areas was
accomplished with the blur tool, going over the area with it to create a more
"life-like"
specimen. While still selected, these areas were colorized using the hue/saturation
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option under image/adjust. As a final means of attracting viewer attention to this area, a
red outline was added via the stroke command, under the edit menu.
Immunoglobulins (Fig. 4)
When this illustration was first created in the Illustrator program, only one light
chain and one IgG molecule were drawn. The remainder are copies of the originals,
scaled (via the image/effects option), rotated, and flipped. The original molecule was
rendered using the airbrush tool, in a similar manner to that used in the creating of the
conceptual piece (Fig. 3), described earlier. Once fully rendered, the molecule was
selected using the pen tool, copied, and pasted. While still selected, it was scaled and
rotated. As previously mentioned, some of the molecules were then flipped, so that the
shadows and highlights remained consistent with the overall image. In some cases, the
scale function disrupted the integrity of the molecules' outlines. In such instances, the
blur tool was used to refine the altered edges. Finally, cast shadows were added
wherever molecules overlapped; this was done with the paintbrush tool.
Kidnevs/HiQhIiQhts (Fig. 7)
The shape and base color of the kidneys were created in Illustrator. In
Photoshop, the magic wand was employed to select the kidneys, masking the area
around them. Rendering entailed the addition of a core shadow, highlights, and
reflected light; all accomplished with the airbrush tool. The inverse option, under the
select menu, allowed for the reversing of the mask; the kidneys were now protected,
while the surrounding area became accessible. A reddish-orange color was chosen and
then airbrushed around the kidneys. The mask left the kidneys untouched by the color.
The result was a highlight which drew attention to the organ being discussed.
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Pie Chart (Fig. 10)
It was a concern that one of the slide graphics represent the different types of multiple
myeloma. A pie chart was chosen to convey the percentage of occurrence of each
type, in a simple, straight forward manner. The chart, like other images within this
series, was created in Adobe Illustrator. However, instead of using geometric tools to
build it, the chart and graph function was employed. By this means, only the
percentages needed to be entered into the dialog box. The program automatically
constructed the chart. Colors were chosen through the style/paint option, and the image
saved. In Photoshop, the outline of the chart were reinforced with the line tool; text was
added as well.
Lead Lines and Arrows
Lead lines, as would be expected, were created with the line tool in Photoshop. The
spheres at their ends came from one sphere, created with the elliptical marquee, filled
under the edit menu, copied, and pasted into place. The arrows were also created
using the line tool. Using the mouse, the line tool icon was double clicked on, activating
the dialog box. The options desired were activated, and values for length and width of
the arrow head were entered
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Conclusion
The goal of this thesis was to create a medical exhibit, with the intent of
introducing the physician and researcher, visually, to multiple myeloma. I would hope
that the artwork presented here is an indication that this goal has been accomplished.
Furthermore, through this thesis report, I've attempted to familiarize the reader with the
workings of multiple myeloma, enough so that the artwork is understood from a scientific
viewpoint. Hopefully, this has been achieved as well.
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FIG. 1. "Multiple Myeloma-Human Interest," Color Pencil & Airbrush, 11"x14"
;>\
FIG. 2. "Overview of
Symptoms," Water Color,
11"x14"
FIG. 3. "Conceptual Representation: Multiple Myeloma Cells and Immunoglobulins Within
the Marrow
Cavity," Airbrush, Water Color & White Charcoal, 14"x17"
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FIG. 4. "Proliferation of Myeloma Cell and Production of Monoclonal (M)
Protein," Slide Graphic, Adobe lllusrator & Photoshop, 6"x9"
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FIG. 5. "Multiple Myeloma; Cell
Histology," Slide Graphic, Adobe lllusrator &
Photoshop,
6"x9"
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FIG. 6. "Multiple Myeloma; Skeletal Involvement," Slide Graphic, Adobe
Illustrator & Photoshop, 6"x9"
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FIG. 7. "Multiple Myeloma; Renal Involvement," Slide Graphic, Adobe lllusrator
& Photoshop,
6"x9"
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FIG. 8. "Multiple Myeloma; Neurologic
Involvement," Slide Graphic, Adobe
Illustrator & Photoshop, 6"x9"
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FIG. 9. "Multiple Myeloma; Mechanism of Bone
Destruction," Slide Graphic,
Adobe lllusrator & Photoshop,
6"x9"
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FIG. 10. "Multiple Myeloma; Frequency in Correlation to the
Paraproteins,"
Slide Graphic, Adobe Illustrator & Photoshop,
6"x9"
